Cuba registers new skin cancer medicine

Posted on Posted in news

Cuba has registered a new skin cancer medicine called “Heberferon” developed by the island’s Genetic Engineering and Biotechnology Center (CIGB) After 20 years of research and clinical trials, Cuba’s Havana-based Genetic Engineering and Biotechnology Center (CIGB) has developed a new medicine called “Heberferon.” BiologistIraldo Bello, who participated in the process, described the drug which combines interferón “Alfa” and interferón “Gamma” through the use of recombinant technology at the CIGB – as “unique” in the world. The injectable medication cures or reduces the size of malignant skin tumors and can prevent scaring from surgery in areas difficult to operate on such […]

Heberprot-P registered in 23 countries

Posted on Posted in news

Ten years after receiving its health registration and approval to be used in the national health system, the medicine Heber¬prot-P has been used to treat over 55,000 Cuban patients nationwide, with positive results Developed by a team of experts led by Dr. Jorge Berlanga Acosta from the Center for Genetic Engineering and Biotechnology (CIGB), Heber­prot-P is an injectable medication used to treat advanced foot ulcers in diabetic patients by accelerating the healing process, thus reducing the risk of amputation in over 78% of cases. The only one of its kind in the world, the product received the Gold Medal awarded […]

Want to Improve the Health of Millions of Americans? Lift the Embargo on Cuba

Posted on Posted in news

By reopening embassies, removing Cuba from the “terror list” and making it a bit easier for Americans to travel there, President Barack Obama’s White House has taken initial steps to put an end to a policy that has adversely affected the health of the American people for over half a century. The Senate Appropriation Committee’s action last week to even further ease restrictions on travel to Cuba by U.S. citizens and relax some provisions of the economic embargo, is welcome for a variety of reasons, but perhaps most urgently for the health of citizens in both countries. Forty years ago, […]

Cuba’s flag flies in Washington

Posted on Posted in news

Washington, D.C — In a ceremony attended by some 500 invited guests on July 20, the Cuban flag was raised over the Cuban Embassy in Washington, D.C., for the first time since 1961, when U.S. imperialism broke relations between the two countries. Other supporters successfully fought back right-wing forces who tried to disrupt the event. Bruno Rodríguez Parrilla, foreign affairs minister of Cuba, told those gathered: “The flag that we revere … is the same that was hauled down here 54 years ago, which was zealously kept in Florida by a family of liberators and later on by the museum […]

As Cuba-US Relations Thaw, Potential Medical Advances Grow

Posted on Posted in news

Recent US steps toward normalizing relations with Cuba after 5 decades may open doors in both countries to medical advances. In December 2014, President Obama reestablished diplomatic relations and eased travel restrictions. In April of this year, Congress removed Cuba from its terror list, and this month, the two countries are expected to resume diplomatic relations and reopen embassies in both countries. Mark Rasenick, PhD, professor of physiology, biophysics, and psychology and director of the biomedical neuroscience training program in the University of Illinois at Chicago College of Medicine, travels to Cuba at least once a year and has testified […]

Cuban Parliamentarian Supports Strengthening Russia-Cuba Cooperation

Posted on Posted in news

Moscow, Jul 7 (Prensa Latina) Cuban parliamentarian and director of the National Center for Sexual Education of Cuba Mariela Castro Espin called today for strengthening cooperation between Cuba and Russia on health, during a meeting with Russian senators. Castro Espin said that the implementation of a joint project for the use, production and technological exchange related to the Cuban drug Heberprot could mean for Russia reduced costs valued at millions of dollars. In addition, she said that a comprehensive program regarding this subject guarantees an increase in life expectancy and quality of life of patients with diabetic foot disease, as […]

Type 11 diabetes cases expected to rise by 200mn globally over next two decades

Posted on Posted in news

Diabetes is the catastrophe of the 21st century, remarked Sir Michael Hirst, the visiting President of the International Diabetes Federation (IDF) headquartered in Brussels, Belgium. This debilitating disease is a challenge to the world, to Sri Lanka and to every other country, he underscored. “No longer are those afflicted old people, even many teenagers are now diabetic”. With a surge in Type 11 diabetes, the number is expected to rise by 200 million globally over the next 20 years, Sir Michael said in an interview with The Sunday Island on the sidelines of the recent launch of Heberprot-P, an innovative […]

Paris-based biotech ABIVAX launches pivotal clinical study on hep B candidate in Asia

Posted on Posted in news

SINGAPORE–Paris-based clinical biotech ABIVAX said it has recruited its first patient for an Asia Pacific-based pivotal Phase IIb-III clinical trial of a potential vaccine therapy of chronic hepatitis B via a controlling viral load for a much longer period of time when compared to current options. The first patient in New Zealand is part of a study to see if the candidate, ABX203, can provide better treatment for chronic hepatitis B. Formulated as a solution for nasal sprays and subcutaneous injections, ABX203 is a therapeutic vaccine designed to induce immune responses similar to those occurring in patients with a self-resolving […]